Fuan Pharmaceutical (Group) Dirección

Dirección controles de criterios 2/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	no data
Participación del CEO	n/a
Permanencia media de la dirección	14.7yrs
Promedio de permanencia en la Junta Directiva	5.9yrs

Actualizaciones recientes de la dirección

Recent updates

Fuan Pharmaceutical (Group)'s (SZSE:300194) Shareholders May Want To Dig Deeper Than Statutory Profit

May 02

Insufficient Growth At Fuan Pharmaceutical (Group) Co., Ltd. (SZSE:300194) Hampers Share Price

Apr 03

CEO

Fuan Pharmaceutical (Group) no tiene CEO, o no tenemos datos al respecto.

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Xue Song Yu	Deputy GM	14.7yrs	CN¥558.90k	0.011% CN¥ 557.0k
Jing Feng	Deputy General Manager	14.7yrs	CN¥561.90k	0.023% CN¥ 1.2m
Rong Chuan Hong	Deputy General Manager	14.7yrs	CN¥496.60k	0.016% CN¥ 815.6k
Yong Ping Sun	Deputy General Manager	3.8yrs	CN¥565.20k	0.025% CN¥ 1.3m
Tao Huang	Deputy GM & Director	11.4yrs	CN¥670.70k	0.74% CN¥ 38.7m
Xionghui Wu	Deputy General Manager	2.4yrs	CN¥561.50k	0.000080% CN¥ 4.2k
Qin Tang	Secretary of the Board of Directors & Director	14.7yrs	CN¥561.90k	0.024% CN¥ 1.3m

14.7yrs

Permanencia media

53yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 300194 es experimentado (14.6 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Xue Song Yu	Deputy GM	14.7yrs	CN¥558.90k	0.011% CN¥ 557.0k
Tao Huang	Deputy GM & Director	11.4yrs	CN¥670.70k	0.74% CN¥ 38.7m
Qin Tang	Secretary of the Board of Directors & Director	14.7yrs	CN¥561.90k	0.024% CN¥ 1.3m
Lu Wang	Vice Chairman	2.4yrs	CN¥687.90k	sin datos
Tianxiang Wang	Chairman	14.7yrs	CN¥875.80k	24% CN¥ 1.3b
Zi Wei Guo	Supervisor	5.9yrs	CN¥197.50k	sin datos
Wei Wang	Director	5.9yrs	CN¥614.00k	sin datos
Wen Shuo Xiong	Independent Director	5.4yrs	CN¥60.00k	sin datos
Shu Zhu	Independent Director	5.4yrs	CN¥60.00k	sin datos
Geng Chen	Independent Director	2.4yrs	CN¥55.00k	sin datos
Yong Yang	Chairman of the Supervisory Board	1.8yrs	sin datos	sin datos

5.9yrs

Permanencia media

53yo

Promedio de edad

Junta con experiencia: La junta directiva de 300194 se considera experimentada (5.8 años de antigüedad promedio).

Fuan Pharmaceutical (Group) Dirección

Dirección controles de criterios 2/4

Información clave

Actualizaciones recientes de la dirección

Fuan Pharmaceutical (Group) Co., Ltd., Annual General Meeting, May 24, 2024

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Fuan Pharmaceutical (Group)'s (SZSE:300194) Shareholders May Want To Dig Deeper Than Statutory Profit

Fuan Pharmaceutical (Group) Co., Ltd. Proposes Final Cash Dividend for 2023

Fuan Pharmaceutical (Group) Co., Ltd., Annual General Meeting, May 24, 2024

First quarter 2024 earnings released: EPS: CN¥0.10 (vs CN¥0.07 in 1Q 2023)

Insufficient Growth At Fuan Pharmaceutical (Group) Co., Ltd. (SZSE:300194) Hampers Share Price

Fuan Pharmaceutical (Group) Co., Ltd. to Report Q1, 2024 Results on Apr 25, 2024

Investor sentiment deteriorates as stock falls 17%

Fuan Pharmaceutical (Group) Co., Ltd. to Report Fiscal Year 2023 Results on Apr 25, 2024

Third quarter 2023 earnings released: EPS: CN¥0.07 (vs CN¥0.04 in 3Q 2022)

Investor sentiment improves as stock rises 19%

Second quarter 2023 earnings released: EPS: CN¥0.07 (vs CN¥0.04 in 2Q 2022)

Fuan Pharmaceutical (Group) Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on 12 May 2023

First quarter 2023 earnings released: EPS: CN¥0.07 (vs CN¥0.03 in 1Q 2022)

Now 22% undervalued

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.04 (vs CN¥0.06 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.04 (vs CN¥0.04 in 2Q 2021)

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Less than half of directors are independent

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Investor sentiment improved over the past week

Second quarter 2021 earnings released: EPS CN¥0.04 (vs CN¥0.05 in 2Q 2020)

Fuan Pharmaceutical (Group) Co., Ltd. Announces Implementation of Profit Distribution Plan for A Shares for the Year 2020, Payable on 14 May 2021

First quarter 2021 earnings released: EPS CN¥0.05 (vs CN¥0.06 in 1Q 2020)

Full year 2020 earnings released: EPS CN¥0.18 (vs CN¥0.25 in FY 2019)

Fuan Pharmaceutical (Group) Co., Ltd. to Report Fiscal Year 2020 Results on Mar 31, 2021

New 90-day low: CN¥4.18

New 90-day low: CN¥4.74

Investor sentiment deteriorated over the past week

New 90-day low: CN¥5.42

New 90-day high - CN¥6.57

Fuan Pharmaceutical (Group) Co., Ltd. to Report First Half, 2020 Results on Aug 28, 2020

New 90-day high - CN¥6.27

CEO

Equipo directivo

Permanencia media

Promedio de edad

Miembros de la Junta

Permanencia media

Promedio de edad